Overview

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
To demonstrate the effects of ciclesonide applied as a nasal aerosol and ciclesonide aqueous (AQ) nasal spray on hypothalamic-pituitary-adrenal axis.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
BB 1101
Ciclesonide
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate